8 companies · 3 sourced backers · 53 milestones on record
AI drug discovery uses machine learning, biological data and molecular modelling to identify and design potential medicines, including therapeutic proteins. Companies are trying to turn computer predictions and automated experiments into a repeatable discovery process that produces safe, effective treatments with demonstrated benefits for patients.
Where the 8 companies stand today, from their profiles and 10-year milestones. Tap a phase to see who is there.
- ▸Turning computational predictions into drug candidates that work in patients.
- ▸Demonstrating the safety and effectiveness of designed molecules.
- ▸Making medicine discovery repeatable rather than producing isolated successes.
- ▸Progressing drug candidates through testing to approval.
Publicly listed: 5 companies (owned by public shareholders).
- ›Every sourced story on all frontiers, filterable by company and news type
- ›10-year milestone records for each company: demo vs shipped
- ›Explained: plain-words readiness diagrams for real breakthroughs
- ›Signal Trends of 39 frontiers covering 378 companies over time.
- ›The events calendar: launches, approvals and deadlines ahead
- Generate Biomedicines
To use generative AI to design useful therapeutic proteins.
Lab · publicly listed
- Genesis Therapeutics
To use deep learning to design molecules that can become medicines.
Lab
- Iambic Therapeutics
To use AI and molecular modelling to design better drug candidates.
Lab · publicly listed
- Insitro
To use machine learning and biological data to discover medicines more systematically.
Trials
- Recursion Pharmaceuticals
To make drug discovery a repeatable, data-driven process using automated biological experiments and AI.
Trials · publicly listed
- Relay Therapeutics
To use understanding of protein motion to design more effective drug candidates.
Trials · publicly listed
- Schrodinger
Full success would mean its physics-based and AI computational platform routinely producing approved drugs and advanced materials, proving that molecules can…
Some users · publicly listed
- Xaira Therapeutics
To use AI as a foundation for discovering and developing medicines.
Lab
Keep following breakthroughs like these. Every Monday, get up to 5 major breakthroughs and launches explained in plain English.
Free. No account needed. One email a week. Unsubscribe anytime.